3-Phosphoinositide-dependent kinase-1 (PDK-1) was identified by its ability to phosphorylate and activate protein kinase B (PKB) in vitro [1,2] and can phosphorylate and activate additional protein kinases in the AGC family in vitro [3-6]. Its role in vivo has, however, only begun to be addressed. We used antisense oligonucleotides directed against PDK-1 expression to explore the role of PDK-1 in human glioblastoma cells (U87-MG), which express a mutant PTEN allele. Reduction in PDK-1 levels resulted in inhibition of PKB activity, and a reduction in phosphorylation on Thr308 and Ser473 of PKB. p70 S6 kinase (p70 S6K ) activity was also reduced. Cell proliferation was dramatically inhibited following treatment with PDK-1 antisense oligonucleotides, due to a combination of decreased cell doubling and an increase in apoptosis. This is in contrast to direct inhibition of phosphoinositide 3-OH kinase (PI 3-kinase), which results in G1 arrest with no effect on apoptosis. This study confirms both PKB and p70 S6K as in vivo substrates for PDK-1. The effect of acute PDK-1 loss on cell proliferation and survival suggests the involvement of PI 3-kinase dependent and independent signaling events, and implicates PDK-1 as a potential therapeutic target for human neoplasms.
Results and discussion
To evaluate the importance of the role of PDK-1 in PI 3-kinase and PKB signaling in vivo we designed and synthesized a panel of 15 chimeric phosphorothioate antisense oligonucleotides targeted against the nucleotide sequence of human PDK-1 [7, 8] . All 15 oligonucleotides (ISIS 20466-20480, here termed 66-80) exhibited activity to various degrees when assayed for their ability to reduce PDK-1 mRNA levels without affecting β-actin mRNA levels. The results for oligonucleotides 71-75 are shown in Figure 1a . We chose two oligonucleotides that were active in several independent experiments (66 5′-AGCTGG-CTGGTGGTCCTGGC-3′ and 71 5′-TGAATGATGCC-CTTGCCGTG-3′, which correspond to nucleotides 4-23 (amino acids 2-8) and 640-659 (amino acids 197-203), respectively), and synthesized control oligonucleotides containing 2, 4, 6 and 8 base-pair (bp) mismatches. Introduction of just two mismatches almost completely abolished the ability to inhibit PDK-1 RNA levels ( Figure 1b ). Oligonucleotide 71 consistently inhibited PDK-1 RNA expression by > 90%, so this, together with its 8 bp mismatch 98, was chosen for further experiments. All experiments were also repeated and confirmed with antisense oligonucleotide 66 and its 8 bp mismatch 94.
To determine the effects of PDK-1 antisense oligonucleotides on levels of PDK-1 protein and on the activity of PKB, we used U87-MG cells, a glioblastoma cell line that expresses a truncated and inactive form of the tumor suppressor phospholipid phosphatase, PTEN, resulting in increased PKB activity [9, 10] . Over a 96 hour posttransfection time course, oligonucleotide 71 dramatically reduced PDK-1 protein levels. Cell numbers increased (data not shown), hence PKB and PDK-1 protein (Figure 1 ) increased during this period in cells treated with oligonucleotide 98. Reduction in PDK-1 levels caused a reduction in PKB activity, similar to that caused by the PI 3-kinase inhibitor LY294002 (Figure 1d ). This suggests that PDK-1 is absolutely required for PKB activation in U87-MG cells. The polyclonal antisera we used to immunoprecipitate PKB recognizes all isoforms (α, β and γ), and the activity of all three was reduced following treatment with PDK-1 antisense oligonucleotides (data not shown).
In vitro, PDK-1 catalyzes phosphorylation of PKB exclusively on Thr-308 [1, 2, 7, 8] . In vivo, however, PKB becomes phosphorylated on both Thr308 and Ser473 following growth factor stimulation [11] . Both phosphorylation sites are dramatically reduced following treatment of U87-MG cells with antisense oligonucleotide 71 but not 98 (Figure 2a ). This suggests that Ser473 is not phosphorylated by a distinctly regulated protein kinase, but does not distinguish between direct, PDK-1 mediated, phosphorylation or PKB autophosphorylation. In addition to PKB, PDK-1 can also phosphorylate other members of the AGC protein kinase family, including p70 S6K , p90 ribosomal S6 kinase (p90 rsk ) and protein kinase C related kinases 1 and 2 (PRKs 1 and 2), at the equivalent phosphorylation site in the activation loop [3] [4] [5] [6] . p70 S6K activity is inhibited following treatment with PDK-1 antisense oligonucleotides (Figure 2b ). In contrast to p70 S6K , p90 rsk and PRKs 1 and 2 were not inhibited by PDK-1 antisense oligonucleotides (data not shown). These AGC kinase family members cannot be ruled out as in vivo PDK-1 substrates, however, as kinase inhibition via our short-term treatment depends on both phosphorylation and dephosphorylation of the PDK-1 site. Indeed, for both p90 rsk and the PRKs this site is highly resistant to protein phosphatases ( [12] , and M. Frodin, personal communication).
We next looked at the biological consequences of a decrease in PDK-1 protein. PDK-1 antisense caused a dramatic inhibition of cell proliferation over a 7 day period following transfection ( Figure 3a) . The degree of inhibition was similar to that achieved by LY294002, which causes arrest of U87-MG cells in the G1 phase of the cell cycle [13] [14] [15] . We therefore investigated whether the effects of PDK-1 antisense on cell proliferation were also mediated through this mechanism. PDK-1 antisense had no effect on the cell-cycle profile of proliferating U87-MG cells (Figure 3b ). They also had only a very modest ability to prevent G2 arrest induced by nocodazole (Figure 3b ), unlike LY294002 (Figure 3b ), and PTEN ( [14] , and data not shown). Therefore, a G1 arrest is unlikely to be the sole reason for the inhibition of cell proliferation. Our results suggest a pathway emanating from PI 3-kinase that controls a G1 checkpoint distinct from that involving PDK-1 and PKB. In support of this, we have been unable to show G1 arrest following expression of a catalytically compromised form of PKB which inhibits endogenous PKB activity, nor have we been able to prevent the G1 arrest induced by LY294002 or PTEN by expressing an activated form of PKB (data not shown).
Despite previous experiments implicating PI 3-kinase and PKB in cell survival signaling, no observable increases in apoptosis are induced by either LY294002 Inhibition of PDK-1 levels reduces PKB phosphorylation on both Thr308 and Ser473, and inhibits p70 S6K activity. U87-MG cells were transfected with either lipofectin alone (Control), or with PDK-1 oligonucleotides 71 and 98 and harvested 48 h later. LY294002 (20 µM) was added to the cells 20 min before harvest. (a) PKB activity was assessed as described for Figure 1 . Equal portions of the lysate were separated by SDS-PAGE and western blotted using antibodies specific for the Thr308 and Ser473 phosphorylated forms of PKB, and with antibody that recognizes total PKB. (b) p70 S6K was immunoprecipitated from equal amounts of total protein and assayed for activity as described in the Supplementary material. A portion of the lysate was separated by SDS-PAGE and western blotted using antibodies specific for p70 S6K . or PTEN in attached U87-MG cells [14, 16] . Terminal dUTP nick end labeling (TUNEL) experiments showed, however, that PDK-1 antisense oligonucleotides caused substantial apoptosis 48 and 72 hours after oligonucleotide administration, effects similar in magnitude to those of tumor necrosis factor (TNF) in the presence of cycloheximide, although somewhat delayed (Figure 4a,b) . The difference between PI 3-kinase inhibition and PDK-1 antisense treatment in their relative abilities to cause apoptosis suggests at least two possibilities. The first is that PDK-1 has substrates in addition to PKB or p70 S6K that could mediate a survival signal independent of PI 3-kinase signaling. The second possibility is that PKB (or another protein in the PI 3-kinase pathway) is the relevant survival substrate, but that inhibition of PI 3-kinase provides additional signals that prevent apoptosis. One possibility in this regard is that cells arrested in G1 are protected from apoptosis. This situation has been Brief Communication 1441
Figure 3
Current Biology described in primary keratinocytes, where induction of growth arrest in G1 protected cells from apoptosis induced by ultraviolet radiation [17] .
We used time-lapse videomicroscopy to analyze the effects of PDK-1 antisense oligonucleotides on U87-MG proliferation and survival over 48 hours, beginning 24 hours posttransfection. The PDK-1-antisense-treated cells were morphologically distinct from controls, with enlarged, flattened cell bodies and reduced motility. Increased apoptosis was also seen towards the end of the time period, confirming the TUNEL experiments (Figure 4) . Surprisingly, and in contrast to the FACS results, there was also a dramatic effect on the cell cycle, as seen by a decrease in the number of mitoses in cells treated with PDK-1 antisense relative to controls when normalized for cell number (see Supplementary material).
While this paper was in preparation, Williams et al. [18] published an analysis of embryonic stem (ES) cells in which a lack of PDK-1 protein expression had been generated by homologous recombination. They showed that PKB activity was abolished, in agreement with our study. However, in contrast to our results , which show simultaneous inhibition of Thr308 and Ser473 phosphorylation, they showed that although Thr308 phosphorylation was bolished, Ser473 phosphorylation was almost unaffected. The reason for this discrepancy is unclear, and shows that the mechanism and role of PKB Ser473 phosphorylation in different cell types under different conditions remains to be clarified. The PDK-1 -/-ES cells were also defective in their ability to cause p70 S6K activation in response to IGF-1; this is consistent with our data showing inhibition of p70 S6K by PDK-1 antisense oligonucleotides. Also, whereas loss of PDK-1 expression in U87-MG cell causes a dramatic decrease in cell proliferation, the PDK-1 -/-ES cells were viable and grew normally. All these discrepancies suggest that the role of PDK-1 may be distinct in different cell types and that the acute removal of PDK-1 protein is not functionally the same as genetic deletion.
The effect of PDK-1 antisense oligonucleotides on proliferation and apoptosis in U87-MG cells suggests that PDK-1 inhibition might be a useful therapeutic strategy under conditions of chronic PI 3-kinase signaling. Investigation into which PDK-1 substrates mediate these effects is currently underway.
Supplementary material
Supplementary material including detailed methodologies, a figure showing mitotic index and movies of U87-MG cell proliferation after antisense treatments is available at http://current-biology.com/supmat/supmatin.htm.
